Skip to content
healthcare.dev

Ranolazine

NDC 70756-703, Ranolazine, tablet, film coated, extended release, from Lifestar Pharma LLC.

Product NDC
70756-703
Status
Listed
Labeler
Lifestar Pharma LLC
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA212284
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70756-703 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RANOLAZINE500 mg/1

Pharmacologic classes

Anti-anginal [EPC]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]; Organic Cation Transporter 2 Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]

Package NDCNDC-11Package
70756-703-607075607036060 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (70756-703-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/195c4b51-fec2-410d-8d90-487c536a8728
  • NADAC price for package 70756070360

    GET /v1/drugs/nadac/70756070360

Use it

Look up 70756-703 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70756-703 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70756-703. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.